دورية أكاديمية
Adoption of RTS, S malaria vaccine for children younger than 5 years in Rwanda: A budget impact analysis.
| العنوان: | Adoption of RTS, S malaria vaccine for children younger than 5 years in Rwanda: A budget impact analysis. |
|---|---|
| المؤلفون: | Ndikumukiza C; Analyda LLC, Boston, MA, United States of America., Yunusa I; College of Pharmacy, University of South Carolina, Columbia, SC, United States of America., Nkurunziza J; Analyda LLC, Boston, MA, United States of America., Chinaeke E; College of Pharmacy, University of South Carolina, Columbia, SC, United States of America., Alshammari FH; Ministry of Health, Saudi Arabia., Abahuje E; Simulation Education Fellow, STRATUS Center for Medical Simulation Brigham and Women's Hospital, Boston, MA, United States of America., Alsahali S; Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Unaizah, Qassim, Saudi Arabia. |
| المصدر: | Exploratory research in clinical and social pharmacy [Explor Res Clin Soc Pharm] 2021 Aug 16; Vol. 3, pp. 100063. Date of Electronic Publication: 2021 Aug 16 (Print Publication: 2021). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918266300706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-2766 (Electronic) Linking ISSN: 26672766 NLM ISO Abbreviation: Explor Res Clin Soc Pharm Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [New York] : Elsevier Inc., [2021]- |
| مستخلص: | Background: In Rwanda, malaria affects one in six children under five years old. Despite being preventable and treatable, malaria causes substantial morbidity, mortality, and economic burden on the Rwandan government and healthcare donors. Recently, the World Health Organization (WHO) agreed to consider the new malaria vaccine (RTS, S) as an additional prevention strategy. The Global Fund, a healthcare donor, is committed to donating more than fifty million US dollars over four years (2018-2021) to fight malaria in Rwanda. We estimated the potential budget impact of the adoption of RTS, S, into the Global Fund budget (as a case study) for malaria prevention in Rwanda. Methods: We developed a static budget impact model based on clinical, epidemiological, and cost (in US dollars) data from the literature, to assess the financial consequences of adding RTS, S to existing prevention strategies. Cost of treatment and prevention for the first year (without vaccine) was estimated and compared to the total cost after the fifth year (with vaccine). A one-way sensitivity analysis evaluated the robustness of the model. Results: For the 283,931children under 5 years at risk of malaria in Rwanda every year, the expected budget for first year (without vaccine) was $1,328,377.71 and for the fifth year (with vaccine) was $3,837,804, yielding a potential budget impact of $2,509,427. The cost of treating un-prevented malaria for the first year was $736,959 and for the fifth year was $61,413. The annual number of malaria treatments avoided increased from 10,095 children in the first year after introduction of vaccine to 36,701 children at the fifth year. Conclusion: With a potential budget impact of $2,509,427, the introduction of malaria vaccine for children under 5 years by Global Fund in Rwanda may be affordable when compared to the amount spent on treating children with malaria. Given that Malaria causes more harm than most parasitic diseases and disproportionally affects low-income populations, it is ethical to deploy all measures to control or eliminate Malaria, including vaccination. Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. (© 2021 The Authors.) |
| References: | Malar J. 2016 Jul 12;15(1):355. (PMID: 27406091) BMJ Glob Health. 2017 Jan 24;2(1):e000090. (PMID: 28588994) Nat Rev Drug Discov. 2015 Sep;14(9):593. (PMID: 26323535) Malar J. 2010 May 30;9:148. (PMID: 20509971) PLoS Med. 2014 Jul 29;11(7):e1001685. (PMID: 25072396) N Engl J Med. 2016 Jun 30;374(26):2519-29. (PMID: 27355532) Lancet. 2015 Jul 4;386(9988):31-45. (PMID: 25913272) Malar J. 2011 May 18;10:134. (PMID: 21592380) MDM Policy Pract. 2019 Dec 10;4(2):2381468319873324. (PMID: 31853505) Acta Clin Belg. 2015 Jun;70(3):175-80. (PMID: 25579611) Am J Trop Med Hyg. 2017 Sep;97(3_Suppl):99-110. (PMID: 28990918) PLoS Biol. 2016 Mar 02;14(3):e1002380. (PMID: 26934361) N Engl J Med. 2011 Nov 17;365(20):1863-75. (PMID: 22007715) Pharmacoeconomics. 2016 Nov;34(11):1111-1131. (PMID: 27334107) |
| فهرسة مساهمة: | Keywords: Budget impact; Children; Malaria; RTS, S; Rwanda; Vaccine |
| تواريخ الأحداث: | Date Created: 20220428 Latest Revision: 20220716 |
| رمز التحديث: | 20240829 |
| مُعرف محوري في PubMed: | PMC9031682 |
| DOI: | 10.1016/j.rcsop.2021.100063 |
| PMID: | 35480603 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2667-2766 |
|---|---|
| DOI: | 10.1016/j.rcsop.2021.100063 |